#1 Clinical Trials Search in Europe

Gallium Citrate Ga-68

Gallium Citrate Ga-68 is emerging as a valuable diagnostic tool in clinical trials, particularly for detecting infections in prosthetic devices. This radioactive tracer is being studied for its potential to improve the accuracy of diagnosing conditions such as prosthetic valve infective endocarditis and chronic infections in artificial hip and knee joints. By using advanced imaging techniques like PET/CT scans, researchers aim to enhance the early detection and management of these challenging medical conditions.

Table of Contents

What is Gallium Citrate Ga-68?

Gallium Citrate Ga-68, also known as 68Ga-citrate or Gallium-68 citrate complex, is a radioactive substance used in medical imaging[1]. It is primarily used as a diagnostic tool in a type of imaging called Positron Emission Tomography/Computed Tomography (PET/CT)[2]. This imaging technique helps doctors visualize and diagnose certain types of infections in the body.

Medical Conditions Diagnosed

Gallium Citrate Ga-68 is being studied for its effectiveness in diagnosing two main types of infections:

  • Prosthetic valve infective endocarditis: This is an infection of the inner lining of the heart (endocardium) that occurs in patients with artificial heart valves[1].
  • Prosthetic joint infections: These are infections that occur in artificial hip or knee joints[2].

Both of these conditions can be challenging to diagnose accurately with conventional methods, which is why researchers are exploring the use of Gallium Citrate Ga-68 PET/CT.

How It Works

When Gallium Citrate Ga-68 is injected into the body, it tends to accumulate in areas of infection or inflammation. During a PET/CT scan, special cameras detect the radiation emitted by the Gallium-68, creating detailed images of the body. These images can help doctors identify the location and extent of infections[1][2].

Administration

Gallium Citrate Ga-68 is administered as a solution for injection. It is typically given intravenously (through a vein) before the PET/CT scan. The maximum dose used in current studies is 150 MBq (megabecquerels, a unit of radioactivity)[1][2].

Benefits of Gallium Citrate Ga-68 PET/CT

Researchers are investigating several potential benefits of using Gallium Citrate Ga-68 PET/CT:

  • Improved accuracy in diagnosing prosthetic valve infective endocarditis and prosthetic joint infections[1][2].
  • Better assessment of infection spread in the chest, abdomen, and pelvis[1].
  • Help in identifying the initial source of infection[1].
  • Potentially higher sensitivity and specificity compared to other imaging techniques[1][2].

Ongoing Research

Currently, Gallium Citrate Ga-68 is being studied in clinical trials to determine its effectiveness. These studies aim to:

  • Estimate the sensitivity and specificity of Gallium Citrate Ga-68 PET/CT in diagnosing prosthetic infections[1][2].
  • Compare its performance to other imaging techniques, such as 18FDG-PET/CT and multinuclear scintigraphy[1][2].
  • Assess the reproducibility of image interpretation between different observers[1][2].

Patient Eligibility

Patients who may be eligible for studies involving Gallium Citrate Ga-68 typically include:

  • Adults over 18 years old[1][2].
  • Individuals with prosthetic heart valves or artificial hip/knee joints[1][2].
  • Patients suspected of having an infection in their prosthetic valve or joint[1][2].

Precautions and Contraindications

While Gallium Citrate Ga-68 PET/CT is being studied for its diagnostic benefits, there are some precautions and contraindications to be aware of:

  • It should not be used in pregnant or breastfeeding women[1][2].
  • Women of childbearing age should use effective contraception[1][2].
  • It may not be suitable for patients with recent cardiac surgery (within 2 months)[1].
  • Patients with progressive cancer may not be eligible for these studies[2].
  • Known hypersensitivity to radiopharmaceuticals or their excipients is a contraindication[1][2].

It’s important to note that Gallium Citrate Ga-68 is still under investigation, and its use is currently limited to clinical trials. Patients should discuss their eligibility and any concerns with their healthcare provider.

Aspect Details
Drug Name Gallium Citrate Ga-68
Form Solution for injection
Dosage Up to 150 MBq (megabecquerels)
Administration Intravenous use
Main Conditions Studied Prosthetic valve infective endocarditis, Chronic prosthetic joint infections (hip and knee)
Imaging Technique PET/CT (Positron Emission Tomography/Computed Tomography)
Primary Objectives Assess diagnostic accuracy (sensitivity, specificity, predictive values) for prosthetic infections
Secondary Objectives Evaluate inter-observer reproducibility, compare with other imaging techniques, assess contribution to infection spread evaluation
Patient Population Adults (over 18) with suspected prosthetic infections
Key Exclusions Pregnancy, breastfeeding, active cancer, inability to stop antibiotics for study period

FAQ

  • What is Gallium Citrate Ga-68 and how is it used in clinical trials? Gallium Citrate Ga-68 is a radioactive tracer used in PET/CT scans. In clinical trials, it's being studied to diagnose infections in prosthetic devices, such as heart valves and artificial joints. It's injected into the patient's body and then detected by special imaging equipment to identify areas of infection.
  • What conditions are being studied using Gallium Citrate Ga-68? The clinical trials are focusing on two main conditions: prosthetic valve infective endocarditis (an infection of artificial heart valves) and chronic infections in artificial hip and knee joints. These conditions can be challenging to diagnose accurately with conventional methods.
  • How does the Gallium Citrate Ga-68 PET/CT compare to other diagnostic methods? The trials aim to compare Gallium Citrate Ga-68 PET/CT with other diagnostic methods like 18FDG-PET/CT for heart valve infections and multinuclear scintigraphy for joint infections. Researchers are assessing whether Gallium Citrate Ga-68 PET/CT offers improved accuracy and reliability in diagnosing these conditions.
  • Who can participate in these clinical trials? Generally, adult patients (over 18 years old) with suspected infections in prosthetic heart valves or artificial hip/knee joints are eligible. However, there are specific inclusion and exclusion criteria, such as the absence of certain medical conditions and the ability to temporarily stop antibiotics for the study.
  • What are the potential benefits of using Gallium Citrate Ga-68 for diagnosis? If successful, Gallium Citrate Ga-68 PET/CT could provide more accurate and earlier diagnosis of prosthetic infections. This could lead to better patient outcomes by allowing for more timely and appropriate treatment. The studies also aim to assess its ability to identify the spread of infection and potential entry points of pathogens.

Ongoing Clinical Trials on Gallium Citrate Ga-68

  • Study on the Use of Gallium Citrate Ga-68 for Diagnosing Chronic Infections in Artificial Hip and Knee Joints

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Gallium Citrate Ga-68 PET/CT for Diagnosing Prosthetic Valve Infective Endocarditis in Patients Suspected of Having the Condition

    Recruiting

    1 1
    Investigated drugs:
    France

Glossary

  • PET/CT: Positron Emission Tomography/Computed Tomography, an imaging technique that combines PET and CT scans to provide detailed pictures of the body's structures and functions.
  • Prosthetic valve infective endocarditis: An infection of the tissue surrounding an artificial heart valve.
  • Chronic prosthetic joint infection: A long-term infection affecting an artificial joint, such as a hip or knee replacement.
  • Scintigraphy: An imaging technique that uses small amounts of radioactive materials to diagnose or treat various diseases.
  • Sensitivity: The ability of a test to correctly identify patients with a disease.
  • Specificity: The ability of a test to correctly identify people without the disease.
  • Inter-observer reproducibility: The degree of agreement among different observers when examining the same data.
  • Radiotracers: Radioactive substances used in medical imaging to highlight specific areas of the body.
  • 18FDG-PET/CT: A type of PET/CT scan that uses a radioactive form of glucose (sugar) to detect areas of high metabolic activity, often associated with cancer or inflammation.
  • Multinuclear scintigraphy: An imaging technique that uses multiple types of radioactive tracers to provide different kinds of information about the body.

References

  1. http://clinicaltrials.eu/trial/study-on-gallium-citrate-ga-68-pet-ct-for-diagnosing-prosthetic-valve-infective-endocarditis-in-patients-suspected-of-having-the-condition/
  2. http://clinicaltrials.eu/trial/study-on-the-use-of-gallium-citrate-ga-68-for-diagnosing-chronic-infections-in-artificial-hip-and-knee-joints/